Healthcare Triangle Expands into Indonesia; Identifying USD 45 Million Opportunity
PR Newswire•02/11/2026•09:15 ET
0
Key Highlights
- ➤Indonesia pipeline estimated at $20–45 million over 24–36 months
- ➤Pipeline is unweighted potential value, not contracted revenue, backlog or guidance
- ➤Healthcare Triangle evaluating Indonesian partnerships and joint venture structures
- ➤Neurotechnology devices require Indonesian health-authority registration before commercial sale
- ➤Current discussions cover neurotechnology pilots, Ziloy.ai wellness programs and Ezovion hospital projects
Expert Statements
David Ayanoglou, Chief Financial Officer of Healthcare Triangle, Inc.
“Indonesia is a strategically important market for us,”
David Ayanoglou, Chief Financial Officer of Healthcare Triangle, Inc.
“Quantum Nexis has built relationships with government, healthcare, wellness and strategic partners. Our priority now is execution: converting these engagements into signed contracts and recurring revenue and building Indonesia into a core part of our ASEAN strategy.”
Healthcare Triangle Expands into Indonesia; Identifying USD 45 Million Opportunity PR Newswire
Company targeting Southeast Asia's largest economy with its Ezovion, Ziloy.ai and neurotechnology platforms and evaluating local partnership and joint venture structures. The targeted pipeline is an internal management estimate and is not contracted revenue or financial guidance.
Get started
Create a free account to read the full story.